Search results for: Health Policy and Regulation
Filter search results
Adrian Towse
6 February 2014
…for health care payers and the pharmaceutical industry; and economic issues that affect both R&D for and access to treatments for diseases prevalent in the low and middle income countries….
The Tougher the Better: The Effect of GP Performance Thresholds in Scotland
20 April 2012
…that the QOF achievement has had a negligible impact on health outcomes. The OHE’s Yan Feng and her colleagues take a closer look at the effect of changes in the…
Lavni Varyani
19 September 2025
…Group (now IQVIA), specializing in market access, pricing pathways, tendering and procurement processes, and commercial effectiveness. Her expertise includes the Saudi HTA system and spans diagnostics and high-value innovations across…
Amanda Cole
30 May 2014
Amanda Cole is a health economist specialising in economic evaluation, reimbursement, real-world evidence, and health policy. She leads OHE’s Economics of Innovation theme and is an Honorary Professor of Practice…
Using Performance Thresholds to Affect GP Behaviour: Evidence from Scotland
4 March 2014
Whether and how a change in performance-related payment motivated change in GP behaviour in Scotland is investigated in a recent article by OHE’s Yan Feng and colleagues, Ada Ma (Hong…
Hania El Banhawi
28 February 2023
…tobacco control policy in low- and middle- income countries and the EU, female genital mutilation across Africa and adolescent sexual and reproductive health in Egypt. Her masters thesis explored the…
OHE at ISPOR Europe 2023
13 November 2023, 12:00am
…of New Antibiotics Look like in the Context of Pull Incentives? The How, What, and Where Next for Antimicrobial Resistance and Health Technology Assessment Grace Hampson 10:15 – 11:15 Spotlight…
Diseases of the Prostate
1 September 1995
…of Treatment; Incidence and Prevalence; Aetiology; Diagnosis; and Treatment. The feasibility of screening, and the cost to the NHS of prostatic diseases, are then discussed in Chapters five and six…
OHE Lunchtime Seminar with Andrea Manca: Economic Evaluation for Decision-making and the Value of Access to Individual Patient Data
16 January 2017
…To successfully support healthcare decision-making, cost-effectiveness analysis (CEA) must consider and synthesise all (relevant) available evidence relating to the clinical effectiveness, health-related quality of life (HRQoL) and costs of the…